The 4th Annual Antibody Drug Conjugates Summit: From Target to Therapeutics scheduled for May 15-16, 2019 in Vienna, Austria which is co-located with 3rd Annual antibody summit: Biscpecific & Multispecific. This premier B2B event provides the appropriate platform to engage and discuss ideas with your fellow peers, while facilitating a professional atmosphere and environment for good company representation and development. The summit will shed light on how ADCs and novel bioconjugates development can be optimised for the future.
More information and registration here
